Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ACADVL ACAD6, LCACD, VLCAD ENSG00000072778 Acyl-CoA dehydrogenase, very long chain 17 7217125-7225273 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA019006, HPA020595 Supported Supported Nucleus
Nucleoli
Mitochondria Pancreatic cancer:6.87e-4 (favourable) Expressed in all Expressed in all adrenal gland: 455.8 AGAP2 CENTG1 ENSG00000135439 ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 12 57723761-57742157 Predicted intracellular proteins Evidence at protein level HPA023474 Approved Supported Nucleus
Nucleoli
Mitochondria Tissue enriched Tissue enriched 7 cerebral cortex: 145.0 lymph node: 20.1 AGBL3 CCP3, MGC32955 ENSG00000146856 ATP/GTP binding protein-like 3 7 134986508-135147963 Enzymes, Predicted intracellular proteins Evidence at protein level HPA020397, HPA024150 Uncertain Uncertain Nuclear speckles
Mitochondria
Cytosol Renal cancer:4.02e-4 (unfavourable) Mixed Mixed testis: 9.3 AIM2 PYHIN4 ENSG00000163568 Absent in melanoma 2 1 159062484-159147096 Predicted intracellular proteins Evidence at protein level HPA031365, HPA040309 Uncertain Supported Nucleoplasm
Mitochondria
Cytosol Mixed Tissue enhanced lymph node: 53.2;spleen: 31.4;tonsil: 41.8 appendix: 26.9 ALDH1B1 ALDH5, ALDHX ENSG00000137124 Aldehyde dehydrogenase 1 family, member B1 9 38392664-38398661 Enzymes, Predicted intracellular proteins Evidence at protein level HPA021037 Approved Supported Nucleoplasm
Vesicles
Mitochondria Thyroid cancer:1.17e-5 (unfavourable), Renal cancer:2.05e-4 (favourable) Expressed in all Expressed in all smooth muscle: 176.4 ANKRD37 Lrp2bp ENSG00000186352 Ankyrin repeat domain 37 4 185396021-185400628 Predicted intracellular proteins Evidence at protein level HPA036626, HPA058127 Uncertain Supported Nucleus
Mitochondria
Cytosol Expressed in all Mixed prostate: 31.3 ARMCX1 ALEX1, GASP7 ENSG00000126947 Armadillo repeat containing, X-linked 1 X 101550531-101554700 Predicted membrane proteins Evidence at protein level HPA005685, CAB020695 Supported Approved Nucleus
Mitochondria
Cytosol Pancreatic cancer:7.32e-5 (favourable), Cervical cancer:3.62e-4 (unfavourable) Expressed in all Expressed in all ovary: 58.9 ATAD1 FLJ14600 ENSG00000138138 ATPase family, AAA domain containing 1 10 87751512-87841343 Enzymes, Predicted membrane proteins Evidence at protein level HPA037569 Uncertain Approved Nucleus
Nucleoli
Mitochondria Renal cancer:3.98e-6 (favourable) Expressed in all Expressed in all parathyroid gland: 28.5 C12orf65 FLJ38663, SPG55 ENSG00000130921 Chromosome 12 open reading frame 65 12 123232916-123257959 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA038194, HPA057595 Uncertain Approved Nucleus
Mitochondria
Cytosol Liver cancer:4.29e-9 (unfavourable), Urothelial cancer:7.82e-5 (favourable) Expressed in all Expressed in all testis: 26.7 C12orf73 DKFZp547P055, FLJ13975 ENSG00000204954 Chromosome 12 open reading frame 73 12 103950202-103965708 Predicted secreted proteins Evidence at protein level HPA038883 Uncertain Approved Plasma membrane
Centrosome
Mitochondria Urothelial cancer:1.61e-4 (favourable), Liver cancer:6.98e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex,thyroid gland: 17.8 C20orf194 DKFZp434N061 ENSG00000088854 Chromosome 20 open reading frame 194 20 3249305-3407625 Predicted intracellular proteins Evidence at protein level HPA052103, HPA067418 Approved Approved Nucleoli fibrillar center
Mitochondria
Cytosol Pancreatic cancer:1.68e-4 (favourable), Renal cancer:7.68e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 26.5 CALHM2 FAM26B ENSG00000138172 Calcium homeostasis modulator 2 10 103446786-103452402 Predicted membrane proteins, Transporters Evidence at protein level HPA014706 Approved Approved Nucleoplasm
Mitochondria
Cytosol Renal cancer:3.03e-6 (unfavourable) Expressed in all Mixed ovary: 44.9 CAMTA2 KIAA0909 ENSG00000108509 Calmodulin binding transcription activator 2 17 4967992-4987652 Predicted intracellular proteins Evidence at protein level HPA051147 Approved Nucleus
Actin filaments
Mitochondria Pancreatic cancer:6.00e-8 (favourable) Expressed in all Expressed in all cerebral cortex: 40.6 CCDC51 FLJ12436 ENSG00000164051 Coiled-coil domain containing 51 3 48432164-48440456 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA010980, HPA011408 Supported Supported Nucleoplasm
Centrosome
Mitochondria Expressed in all Mixed thyroid gland: 17.2 CD3EAP ASE-1, CAST, PAF49 ENSG00000117877 CD3e molecule, epsilon associated protein 19 45406209-45410766 Predicted intracellular proteins Evidence at protein level HPA041664, HPA041734 Supported Validated Nucleus
Nucleoli fibrillar center
Mitochondria Liver cancer:4.79e-9 (unfavourable) Expressed in all Mixed appendix: 5.6 CEACAM19 CEAL1 ENSG00000186567 Carcinoembryonic antigen-related cell adhesion molecule 19 19 44662278-44684359 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA014462, HPA052865 Uncertain Approved Nucleus
Nucleoli
Mitochondria Expressed in all Mixed skin: 12.7 CHCHD1 C10orf34, FLJ25854 ENSG00000172586 Coiled-coil-helix-coiled-coil-helix domain containing 1 10 73782047-73783652 Predicted intracellular proteins Evidence at protein level HPA039046 Approved Supported Nucleoplasm
Nucleoli fibrillar center
Mitochondria Urothelial cancer:5.42e-4 (favourable) Expressed in all Expressed in all epididymis: 61.6 COA4 CHCHD8, CMC3, E2IG2 ENSG00000181924 Cytochrome c oxidase assembly factor 4 homolog 11 73872667-73876988 Predicted intracellular proteins Evidence at protein level HPA040126 Approved Approved Nucleus
Nucleoli fibrillar center
Mitochondria Renal cancer:2.14e-4 (unfavourable), Ovarian cancer:3.87e-4 (favourable) Expressed in all Expressed in all adrenal gland: 81.8 CORO7-PAM16 ENSG00000103426 CORO7-PAM16 readthrough 16 4340251-4420494 Predicted intracellular proteins Evidence at protein level HPA041657, HPA053586, HPA062721 Uncertain Approved Nucleoplasm
Microtubules
Mitochondria Not detected Not detected testis: 0.2 COX10 ENSG00000006695 COX10 heme A:farnesyltransferase cytochrome c oxidase assembly factor 17 14069496-14208677 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA032005, HPA032006 Supported Supported Nucleoli
Mitochondria
Cytosol Renal cancer:4.32e-6 (favourable), Stomach cancer:8.73e-4 (favourable) Expressed in all Expressed in all testis: 43.0 CPNE2 CPN2 ENSG00000140848 Copine II 16 57092537-57148367 Predicted intracellular proteins Evidence at protein level HPA041132 Approved Approved Nucleoplasm
Mitochondria
Cytosol Expressed in all Expressed in all lung: 55.7 CPT2 CPT1, CPTASE ENSG00000157184 Carnitine palmitoyltransferase 2 1 53196429-53214197 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA028201, HPA028202, HPA028214 Supported Supported Nucleoplasm
Nucleoli
Mitochondria Renal cancer:1.46e-12 (favourable), Colorectal cancer:5.27e-4 (favourable) Expressed in all Expressed in all liver: 42.1 CREB3L4 AIbZIP, ATCE1, CREB3, CREB4, hJAL ENSG00000143578 CAMP responsive element binding protein 3-like 4 1 153967534-153974363 Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA038122 Supported Approved Nucleoplasm
Nuclear membrane
Mitochondria Endometrial cancer:7.21e-4 (favourable) Group enriched Expressed in all prostate: 171.5 CREBL2 ENSG00000111269 CAMP responsive element binding protein-like 2 12 12611827-12645108 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA043738 Uncertain Approved Nucleoplasm
Mitochondria
Cytosol Renal cancer:2.26e-5 (favourable) Expressed in all Expressed in all adrenal gland: 174.3 CTNNBIP1 ICAT, MGC15093 ENSG00000178585 Catenin, beta interacting protein 1 1 9848276-9910336 Predicted intracellular proteins Evidence at protein level HPA042617 Approved Plasma membrane
Cell Junctions
Mitochondria Endometrial cancer:5.68e-6 (favourable) Expressed in all Expressed in all skin: 288.8 CUEDC1 ENSG00000180891 CUE domain containing 1 17 57861243-57955323 Predicted intracellular proteins Evidence at protein level HPA023050, HPA024836 Approved Uncertain Centrosome
Mitochondria
Cytosol Liver cancer:2.65e-5 (unfavourable), Renal cancer:8.46e-4 (favourable) Expressed in all Expressed in all fallopian tube: 51.8 CYB5R1 humb5R2, NQO3A2 ENSG00000159348 Cytochrome b5 reductase 1 1 202961869-202967280 Enzymes, Predicted intracellular proteins Evidence at protein level HPA010641, HPA014147 Supported Uncertain Nucleoli
Mitochondria
Cytosol Endometrial cancer:1.14e-4 (favourable) Expressed in all Expressed in all skeletal muscle: 183.8 CYP24A1 CP24, CYP24, P450-CC24 ENSG00000019186 Cytochrome P450, family 24, subfamily A, polypeptide 1 20 54153449-54173973 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA022261, HPA063771 Supported Supported Nucleoplasm
Plasma membrane
Mitochondria Mixed Tissue enhanced endometrium: 24.8;urinary bladder: 52.7 placenta: 13.9 DAP ENSG00000112977 Death-associated protein 5 10679230-10761272 Predicted intracellular proteins Evidence at protein level HPA029456 Uncertain Approved Nucleoplasm
Vesicles
Mitochondria Liver cancer:2.15e-5 (unfavourable) Expressed in all Expressed in all parathyroid gland: 153.7 DDX28 FLJ11282, MDDX28 ENSG00000182810 DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 16 68021274-68023442 Enzymes, Predicted secreted proteins Evidence at protein level HPA041911, HPA053585 Approved Supported Nucleoli
Mitochondria
Cytosol Renal cancer:2.07e-10 (favourable) Expressed in all Expressed in all bone marrow: 11.2 DGKA DAGK, DAGK1, DGK-alpha ENSG00000065357 Diacylglycerol kinase, alpha 80kDa 12 55927319-55954027 Enzymes, Predicted intracellular proteins Evidence at protein level HPA041645, HPA045462 Approved Approved Nucleoplasm
Vesicles
Mitochondria Renal cancer:1.66e-5 (unfavourable) Expressed in all Mixed skin: 97.3 DPF1 BAF45b, NEUD4, neuro-d4 ENSG00000011332 D4, zinc and double PHD fingers family 1 19 38211006-38229714 Predicted intracellular proteins Evidence at protein level HPA049148 Supported Approved Nucleoplasm
Mitochondria
Cytosol Tissue enhanced Tissue enriched 15 cerebral cortex: 27.5 testis: 1.8 ECHDC3 FLJ20909 ENSG00000134463 Enoyl CoA hydratase domain containing 3 10 11742366-11764070 Predicted intracellular proteins Evidence at protein level HPA038306 Supported Approved Nucleus
Nucleoli
Mitochondria Renal cancer:3.43e-4 (favourable), Urothelial cancer:3.91e-4 (unfavourable) Expressed in all Expressed in all adipose tissue: 76.3 FAM210A C18orf19, HsT2329, MGC24180 ENSG00000177150 Family with sequence similarity 210, member A 18 13663347-13726663 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014324, HPA051564 Uncertain Approved Nucleus
Golgi apparatus
Mitochondria Head and neck cancer:8.14e-4 (unfavourable) Expressed in all Mixed testis: 15.7 FKBP8 FKBP38, FKBPr38 ENSG00000105701 FK506 binding protein 8, 38kDa 19 18531751-18544077 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB025346, HPA045177 Supported Supported Endoplasmic reticulum
Mitochondria
Cytosol Colorectal cancer:1.24e-4 (unfavourable), Pancreatic cancer:7.76e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 355.7 FKBP9 FKBP60, FKBP63 ENSG00000122642 FK506 binding protein 9, 63 kDa 7 32957404-33006931 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA012595, HPA055256 Approved Approved Golgi apparatus
Vesicles
Mitochondria Urothelial cancer:7.02e-6 (unfavourable), Head and neck cancer:2.02e-4 (unfavourable), Cervical cancer:4.22e-4 (unfavourable), Glioma:8.06e-4 (unfavourable), Liver cancer:8.69e-4 (unfavourable) Expressed in all Expressed in all placenta: 109.6 FOXN4 ENSG00000139445 Forkhead box N4 12 109277979-109309220 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA050018 Uncertain Approved Nucleus
Mitochondria
Cytosol Tissue enhanced Tissue enriched 13 testis: 10.7 cervix, uterine: 0.7 GART PGFT, PRGS ENSG00000159131 Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase 21 33503931-33543491 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA002119, HPA005779 Approved Uncertain Nucleoplasm
Mitochondria
Cytosol Renal cancer:3.95e-6 (unfavourable), Head and neck cancer:5.05e-5 (unfavourable), Liver cancer:9.82e-5 (unfavourable), Pancreatic cancer:2.19e-4 (unfavourable) Expressed in all Expressed in all testis: 55.3 GPN1 ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1 ENSG00000198522 GPN-loop GTPase 1 2 27628247-27651508 Predicted intracellular proteins Evidence at protein level HPA036793, HPA036794, CAB037303 Uncertain Supported Nucleoplasm
Mitochondria
Cytosol Liver cancer:1.71e-5 (unfavourable), Endometrial cancer:2.88e-5 (unfavourable) Expressed in all Expressed in all testis: 47.2 GPR87 GPR95 ENSG00000138271 G protein-coupled receptor 87 3 151294086-151316952 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level HPA066313 Approved Nucleoplasm
Lipid droplets
Mitochondria Pancreatic cancer:4.62e-6 (unfavourable) Group enriched Tissue enhanced esophagus: 29.4;skin: 29.8 placenta: 11.9 HINT3 FLJ33126 ENSG00000111911 Histidine triad nucleotide binding protein 3 6 125956781-125980244 Predicted intracellular proteins Evidence at protein level HPA027914 Approved Supported Nucleoli
Mitochondria
Cytosol Renal cancer:1.05e-6 (favourable), Breast cancer:4.99e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 49.8 HIVEP1 CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A ENSG00000095951 Human immunodeficiency virus type I enhancer binding protein 1 6 12008762-12164999 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050724 Approved Supported Nucleoplasm
Nuclear bodies
Mitochondria Expressed in all Mixed parathyroid gland: 25.7 HKR1 ZNF875 ENSG00000181666 HKR1, GLI-Kruppel zinc finger family member 19 37312837-37369365 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA036126, HPA044855 Approved Supported Nucleoplasm
Golgi apparatus
Mitochondria Prostate cancer:5.18e-5 (unfavourable), Pancreatic cancer:4.41e-4 (favourable) Expressed in all Expressed in all thyroid gland: 54.4 HNRNPLL HNRPLL ENSG00000143889 Heterogeneous nuclear ribonucleoprotein L-like 2 38561978-38603586 Predicted intracellular proteins Evidence at protein level HPA046084 Approved Approved Nucleus
Mitochondria
Cytosol Liver cancer:1.22e-4 (unfavourable) Expressed in all Expressed in all testis: 37.3 HSCB DNAJC20, HSC20, Jac1 ENSG00000100209 HscB mitochondrial iron-sulfur cluster co-chaperone 22 28742031-28757515 Predicted intracellular proteins Evidence at protein level HPA018447, HPA031518 Uncertain Supported Nucleus
Mitochondria
Cytosol Endometrial cancer:3.78e-4 (favourable), Urothelial cancer:8.38e-4 (favourable) Expressed in all Expressed in all adrenal gland: 13.3 ICAM3 CD50, CDW50, ICAM-R ENSG00000076662 Intercellular adhesion molecule 3 19 10333776-10339823 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB002498, HPA049820 Supported Approved Nucleus
Nuclear membrane
Mitochondria Mixed Expressed in all bone marrow: 112.2 IFT57 ESRRBL1, FLJ10147, HIPPI, MHS4R2 ENSG00000114446 Intraflagellar transport 57 3 108160812-108222570 Predicted intracellular proteins Evidence at protein level HPA035514, HPA035515 Supported Approved Nuclear speckles
Mitochondria
Cytosol Colorectal cancer:6.96e-5 (favourable), Ovarian cancer:7.63e-4 (favourable) Expressed in all Mixed testis: 66.7 ILF3 DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1 ENSG00000129351 Interleukin enhancer binding factor 3, 90kDa 19 10654261-10692417 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA001897 Supported Supported Nucleoplasm
Nucleoli
Mitochondria Melanoma:1.57e-4 (unfavourable), Renal cancer:9.65e-4 (unfavourable) Expressed in all Expressed in all testis: 149.2 LRIT3 CSNB1F, FIGLER4, FLJ44691 ENSG00000183423 Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3 4 109848202-109872315 Disease related genes, Predicted membrane proteins Evidence at protein level HPA013454 Uncertain Approved Nucleoplasm
Mitochondria
Cytosol Not detected Not detected kidney: 0.9 LRP12 FLJ12929, ST7 ENSG00000147650 Low density lipoprotein receptor-related protein 12 8 104489231-104589024 Predicted membrane proteins Evidence at protein level HPA017245 Uncertain Approved Nucleoli fibrillar center
Plasma membrane
Mitochondria Endometrial cancer:2.67e-4 (unfavourable) Expressed in all Mixed endometrium: 27.6 LRP4 CLSS, LRP-4, MEGF7, SOST2 ENSG00000134569 Low density lipoprotein receptor-related protein 4 11 46856868-46918642 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA011934, HPA012300 Approved Uncertain Nucleus
Nucleoli
Mitochondria Expressed in all Tissue enhanced cerebral cortex: 35.5;skin: 38.0 parathyroid gland: 12.9 LRRC28 FLJ34269, FLJ45242, MGC24976 ENSG00000168904 Leucine rich repeat containing 28 15 99251362-99390729 Predicted intracellular proteins Evidence at transcript level HPA039378, HPA040784, HPA066130 Approved Approved Nucleus
Golgi apparatus
Mitochondria Ovarian cancer:9.97e-5 (favourable), Cervical cancer:1.41e-4 (favourable) Expressed in all Expressed in all testis: 50.0 MBTPS2 KFSD, S2P ENSG00000012174 Membrane-bound transcription factor peptidase, site 2 X 21839636-21885424 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level HPA005494, CAB009486 Approved Approved Nucleoplasm
Mitochondria
Cytosol Expressed in all Expressed in all parathyroid gland: 19.0 METTL25 C12orf26, FLJ22789 ENSG00000127720 Methyltransferase like 25 12 82358497-82479236 Predicted intracellular proteins Evidence at protein level HPA039534, HPA041207 Uncertain Uncertain Plasma membrane
Mitochondria
Cytosol Expressed in all Mixed testis: 13.3 MPPED2 239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638 ENSG00000066382 Metallophosphoesterase domain containing 2 11 30384493-30586872 Predicted intracellular proteins Evidence at protein level HPA062575 Approved Nucleoli
Vesicles
Mitochondria Mixed Tissue enhanced cervix, uterine: 38.4;thyroid gland: 43.4 prostate: 21.5 MRPL44 FLJ12701, FLJ13990 ENSG00000135900 Mitochondrial ribosomal protein L44 2 223957404-223967714 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA038147, HPA038148 Approved Approved Nucleus
Plasma membrane
Mitochondria Liver cancer:1.29e-4 (unfavourable), Renal cancer:2.02e-4 (favourable) Expressed in all Expressed in all kidney: 37.2 MRPL46 C15orf4, LIECG2, P2ECSL ENSG00000259494 Mitochondrial ribosomal protein L46 15 88459476-88467419 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA050166 Uncertain Supported Nucleoplasm
Cell Junctions
Mitochondria Renal cancer:2.09e-6 (favourable) Expressed in all Expressed in all adrenal gland: 50.5 MUL1 C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218 ENSG00000090432 Mitochondrial E3 ubiquitin protein ligase 1 1 20499448-20508161 Predicted membrane proteins Evidence at protein level HPA026827 Approved Nucleoplasm
Mitochondria
Cytosol Renal cancer:6.15e-14 (favourable) Expressed in all Expressed in all parathyroid gland: 39.0 MXD1 bHLHc58, MAD, MAD1 ENSG00000059728 MAX dimerization protein 1 2 69897688-69942945 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA001599 Supported Uncertain Nucleoplasm
Mitochondria
Cytosol Endometrial cancer:8.14e-6 (unfavourable), Pancreatic cancer:8.50e-4 (unfavourable) Expressed in all Tissue enhanced bone marrow: 114.0;esophagus: 102.3 appendix: 57.5 MYBPH ENSG00000133055 Myosin binding protein H 1 203167811-203175813 Predicted intracellular proteins Evidence at protein level HPA061383 Approved Nucleus
Nucleoli
Mitochondria Group enriched Tissue enhanced prostate: 4.2;skeletal muscle: 7.9 esophagus: 1.2 MYD88 ENSG00000172936 Myeloid differentiation primary response 88 3 38138478-38143022 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB009104 Approved Supported Vesicles
Mitochondria
Cytosol Breast cancer:8.45e-4 (favourable) Expressed in all Mixed appendix: 57.6 MYH10 NMMHCB ENSG00000133026 Myosin, heavy chain 10, non-muscle 17 8474205-8630761 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB017180, HPA047541, HPA057198 Supported Validated Actin filaments
Mitochondria
Cytosol Renal cancer:1.38e-4 (favourable), Urothelial cancer:6.42e-4 (unfavourable) Expressed in all Expressed in all lung: 81.2 MYH15 KIAA1000 ENSG00000144821 Myosin, heavy chain 15 3 108380369-108529322 Predicted intracellular proteins Evidence at protein level HPA034871 Uncertain Approved Nucleoplasm
Centrosome
Mitochondria Not detected Tissue enhanced cerebral cortex: 1.9 rectum: 1.3 NARS2 DFNB94, FLJ23441, SLM5 ENSG00000137513 Asparaginyl-tRNA synthetase 2, mitochondrial (putative) 11 78435961-78574874 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA026793 Supported Approved Nucleoplasm
Mitochondria
Cytosol Renal cancer:1.22e-6 (favourable), Ovarian cancer:1.39e-5 (favourable) Expressed in all Expressed in all kidney: 19.7 NGDN C14orf120, DKFZP564O092, LCP5, lpd-2, NGD ENSG00000129460 Neuroguidin, EIF4E binding protein 14 23469688-23509862 Predicted intracellular proteins Evidence at protein level HPA000944 Approved Approved Nucleus
Nucleoli
Mitochondria Expressed in all Expressed in all endometrium: 54.8 NLRX1 CLR11.3, NOD9 ENSG00000160703 NLR family member X1 11 119166568-119184016 Predicted intracellular proteins Evidence at protein level HPA061516 Supported Supported Plasma membrane
Cell Junctions
Mitochondria Renal cancer:2.59e-6 (favourable), Endometrial cancer:2.47e-5 (favourable) Expressed in all Expressed in all esophagus: 37.9 NOL6 bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22 ENSG00000165271 Nucleolar protein 6 (RNA-associated) 9 33461441-33473930 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA055891, HPA061002 Supported Validated Nucleus
Nucleoli
Mitochondria Liver cancer:4.83e-5 (unfavourable), Thyroid cancer:9.49e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 28.1 NOL7 C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1 ENSG00000225921 Nucleolar protein 7, 27kDa 6 13615327-13632739 Predicted intracellular proteins Evidence at protein level HPA029185, HPA049693 Supported Validated Nucleus
Nucleoli
Mitochondria Ovarian cancer:3.64e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 91.5 NPY1R NPYR ENSG00000164128 Neuropeptide Y receptor Y1 4 163323961-163344832 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA029903 Approved Nucleus
Mitochondria
Cytosol Breast cancer:7.68e-5 (favourable) Tissue enriched Tissue enhanced spleen: 153.9 breast: 39.0 NR3C1 GR, GRL ENSG00000113580 Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) 5 143277931-143435512 Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA004248, CAB010435 Supported Validated Nucleoplasm
Mitochondria
Cytosol Renal cancer:1.72e-6 (unfavourable), Endometrial cancer:3.64e-5 (unfavourable) Expressed in all Expressed in all placenta: 66.4 NUDT9 MGC3037 ENSG00000170502 Nudix (nucleoside diphosphate linked moiety X)-type motif 9 4 87422582-87459454 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA036917, HPA044866, HPA078535 Approved Supported Nuclear membrane
Cell Junctions
Mitochondria Renal cancer:8.00e-11 (favourable), Endometrial cancer:7.43e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 84.9 NUP58 KIAA0410, NUP45, NUPL1 ENSG00000139496 Nucleoporin 58kDa 13 25301524-25349800 Predicted intracellular proteins, Transporters Evidence at protein level HPA039360 Approved Approved Plasma membrane
Mitochondria
Cytosol Cervical cancer:2.57e-4 (unfavourable), Liver cancer:3.56e-4 (unfavourable) Expressed in all Expressed in all testis: 86.6 P4HA1 C-P4Halpha(I), P4HA ENSG00000122884 Prolyl 4-hydroxylase, alpha polypeptide I 10 73007217-73096974 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level HPA007599, HPA026593 Supported Supported Endoplasmic reticulum
Vesicles
Mitochondria Renal cancer:9.40e-9 (unfavourable), Head and neck cancer:1.19e-5 (unfavourable), Cervical cancer:3.19e-5 (unfavourable), Pancreatic cancer:2.85e-4 (unfavourable), Lung cancer:5.10e-4 (unfavourable), Breast cancer:9.01e-4 (unfavourable) Expressed in all Expressed in all placenta: 91.1 PAGE1 CT16.3, GAGE-9, GAGEB1, PAGE-1 ENSG00000068985 P antigen family, member 1 (prostate associated) X 49687450-49695993 Predicted intracellular proteins Evidence at protein level HPA003473 Supported Approved Nucleus
Nucleoli fibrillar center
Mitochondria Tissue enhanced Tissue enriched 170 testis: 24.9 epididymis,placenta: 0.1 PAM16 Magmas, Tim16, TIMM16 ENSG00000217930 Presequence translocase-associated motor 16 homolog (S. cerevisiae) 16 4331549-4355607 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA062721 Approved Nucleoplasm
Microtubules
Mitochondria Renal cancer:5.73e-5 (unfavourable), Urothelial cancer:1.33e-4 (favourable) Expressed in all Expressed in all testis: 15.2 PARP9 BAL, BAL1 ENSG00000138496 Poly (ADP-ribose) polymerase family, member 9 3 122527924-122564577 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA066708 Supported Nucleoplasm
Mitochondria
Cytosol Ovarian cancer:6.65e-4 (favourable) Expressed in all Expressed in all spleen: 61.9 PDHX DLDBP, E3BP, OPDX, PDX1, proX ENSG00000110435 Pyruvate dehydrogenase complex, component X 11 34915829-35020591 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA038484, HPA038485 Supported Approved Nucleus
Plasma membrane
Mitochondria Renal cancer:1.83e-5 (favourable) Expressed in all Expressed in all testis: 51.8 PDP1 PDH, PDP, PPM2C ENSG00000164951 Pyruvate dehyrogenase phosphatase catalytic subunit 1 8 93857807-93926066 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA018483, HPA019081, HPA021152 Uncertain Supported Nucleoplasm
Mitochondria
Cytosol Renal cancer:8.42e-9 (favourable), Breast cancer:8.61e-5 (unfavourable), Ovarian cancer:5.60e-4 (unfavourable) Expressed in all Expressed in all adrenal gland: 82.7 PGF D12S1900, PGFL, PLGF, PlGF-2, SHGC-10760 ENSG00000119630 Placental growth factor 14 74941834-74955784 Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level HPA041624 Approved Nucleoplasm
Mitochondria
Cytosol Renal cancer:1.33e-6 (unfavourable), Liver cancer:1.40e-4 (unfavourable) Expressed in all Tissue enhanced placenta: 70.9;thyroid gland: 64.4 cervix, uterine: 29.9 PLD5 FLJ40773 ENSG00000180287 Phospholipase D family, member 5 1 242082986-242524696 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA028389, HPA050367 Uncertain Approved Vesicles
Mitochondria
Cytosol Tissue enhanced Mixed cerebral cortex: 4.2 PLK2 SNK ENSG00000145632 Polo-like kinase 2 5 58453982-58460260 Enzymes, Predicted intracellular proteins Evidence at protein level CAB009624, HPA069329 Approved Approved Nucleoplasm
Mitochondria
Cytosol Renal cancer:2.08e-4 (unfavourable) Expressed in all Expressed in all spleen: 97.3 PNPLA3 adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon ENSG00000100344 Patatin-like phospholipase domain containing 3 22 43923739-43964488 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA058058 Approved Approved Nucleoli
Mitochondria
Cytosol Tissue enhanced Tissue enhanced liver: 16.2 kidney: 4.7 PPCS FLJ11838 ENSG00000127125 Phosphopantothenoylcysteine synthetase 1 42456117-42473385 Enzymes, Predicted intracellular proteins Evidence at protein level HPA031361, HPA031363 Approved Approved Nucleus
Nucleoli fibrillar center
Mitochondria Liver cancer:5.96e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 110.1 PPP1R3D PPP1R6 ENSG00000132825 Protein phosphatase 1, regulatory subunit 3D 20 59936668-59940297 Predicted intracellular proteins Evidence at protein level HPA041146 Approved Approved Nucleoli
Vesicles
Mitochondria Stomach cancer:9.14e-4 (favourable) Expressed in all Mixed parathyroid gland: 10.9 PSTPIP2 ENSG00000152229 Proline-serine-threonine phosphatase interacting protein 2 18 45983536-46072272 Predicted intracellular proteins Evidence at protein level HPA040923, HPA040944 Supported Approved Nucleus
Plasma membrane
Mitochondria Renal cancer:2.39e-7 (unfavourable) Expressed in all Tissue enhanced bone marrow: 47.3;spleen: 70.7 placenta: 17.3 PUS10 CCDC139, FLJ32312 ENSG00000162927 Pseudouridylate synthase 10 2 60940222-61018259 Predicted intracellular proteins Evidence at protein level HPA044736, HPA049582 Approved Approved Nucleoplasm
Nuclear bodies
Mitochondria Expressed in all Mixed thyroid gland: 10.2 RAD51 BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA ENSG00000051180 RAD51 recombinase 15 40694774-40732339 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level CAB010381, HPA039310 Approved Validated Nucleoli
Mitochondria
Cytosol Breast cancer:7.94e-4 (unfavourable), Liver cancer:9.33e-4 (unfavourable) Expressed in all Tissue enhanced testis: 45.1 lymph node,tonsil: 13.2 REXO2 CGI-114, DKFZP566E144, SFN ENSG00000076043 RNA exonuclease 2 11 114439386-114450279 Predicted intracellular proteins Evidence at protein level HPA038450, HPA038451 Supported Supported Nucleoli
Focal adhesion sites
Mitochondria Colorectal cancer:6.51e-4 (favourable), Urothelial cancer:6.70e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 254.4 RGS3 C2PA, FLJ20370, PDZ-RGS3 ENSG00000138835 Regulator of G-protein signaling 3 9 113444731-113597743 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB032507, HPA041109 Validated Nucleoplasm
Mitochondria
Cytosol Liver cancer:6.62e-4 (unfavourable), Breast cancer:9.93e-4 (unfavourable) Expressed in all Expressed in all gallbladder: 66.7 RPS6KA6 RSK4 ENSG00000072133 Ribosomal protein S6 kinase, 90kDa, polypeptide 6 X 84058346-84187907 Enzymes, Predicted intracellular proteins Evidence at protein level HPA002852, HPA003904 Uncertain Supported Nucleus
Nucleoli
Mitochondria Mixed Tissue enhanced parathyroid gland: 18.6;thyroid gland: 21.8 kidney: 8.8 RRP15 CGI-115, KIAA0507 ENSG00000067533 Ribosomal RNA processing 15 homolog 1 218285287-218337983 Predicted intracellular proteins Evidence at protein level HPA024639 Approved Approved Nucleus
Nucleoli
Mitochondria Liver cancer:4.26e-5 (unfavourable) Expressed in all Mixed parathyroid gland: 7.7 SDHAF2 C11orf79, FLJ20487, PGL2, SDH5 ENSG00000167985 Succinate dehydrogenase complex assembly factor 2 11 61430042-61447529 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA039464, HPA039732 Supported Supported Nucleoli
Mitochondria
Cytosol Expressed in all Expressed in all fallopian tube: 35.7 SDHB SDH, SDH1 ENSG00000117118 Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) 1 17018722-17054170 Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA002868, CAB009822, CAB068233, CAB068234, CAB068235 Supported Supported Nucleoplasm
Plasma membrane
Mitochondria Renal cancer:2.93e-7 (favourable) Expressed in all Expressed in all kidney: 213.3 SIRT1 SIR2L1 ENSG00000096717 Sirtuin 1 10 67884669-67918390 Predicted intracellular proteins Evidence at protein level CAB003855, HPA006295, HPA052351 Approved Validated Nucleus
Mitochondria
Cytosol Expressed in all Expressed in all testis: 48.8 SLC25A36 FLJ10618, PNC2 ENSG00000114120 Solute carrier family 25 (pyrimidine nucleotide carrier), member 36 3 140941830-140979933 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA027036 Approved Approved Nucleus
Mitochondria
Cytosol Urothelial cancer:1.55e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 68.3 SMPDL3A ASM3A, ASML3a, FLJ20177, yR36GH4.1 ENSG00000172594 Sphingomyelin phosphodiesterase, acid-like 3A 6 122789049-122809720 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA030148 Uncertain Approved Nucleus
Nucleoli
Mitochondria Colorectal cancer:6.11e-4 (favourable) Expressed in all Expressed in all small intestine: 83.5 SMYD2 HSKM-B, KMT3C, ZMYND14 ENSG00000143499 SET and MYND domain containing 2 1 214281102-214337131 Enzymes, Predicted intracellular proteins Evidence at protein level HPA029023 Uncertain Approved Intermediate filaments
Mitochondria
Cytosol Cervical cancer:1.53e-5 (unfavourable), Renal cancer:8.68e-4 (favourable) Expressed in all Expressed in all heart muscle: 126.2 SPATA2L C16orf76, MGC26885, tamo ENSG00000158792 Spermatogenesis associated 2-like 16 89696343-89701705 Predicted intracellular proteins Evidence at protein level HPA041182, HPA042453 Uncertain Approved Nucleoplasm
Mitochondria
Cytosol Expressed in all Mixed cerebral cortex: 9.2 SPATA7 HSD3, LCA3 ENSG00000042317 Spermatogenesis associated 7 14 88384924-88470350 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA038082, HPA038083 Supported Approved Nucleoplasm
Mitochondria
Cytosol Renal cancer:2.50e-5 (favourable), Pancreatic cancer:4.16e-5 (favourable) Expressed in all Expressed in all testis: 102.2 SREBF2 bHLHd2, SREBP2 ENSG00000198911 Sterol regulatory element binding transcription factor 2 22 41833079-41907308 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA031962, HPA031963 Approved Supported Nucleoplasm
Vesicles
Mitochondria Renal cancer:1.37e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 118.8 SS18L2 KIAA-iso ENSG00000008324 Synovial sarcoma translocation gene on chromosome 18-like 2 3 42581840-42595114 Predicted intracellular proteins Evidence at protein level HPA047377 Uncertain Approved Nucleus
Nucleoli
Mitochondria Lung cancer:7.03e-4 (favourable) Expressed in all Expressed in all lymph node: 58.8 TAGLN DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10 ENSG00000149591 Transgelin 11 117199321-117204782 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB001447, HPA019467 Supported Approved Microtubules
Mitochondria
Cytosol Renal cancer:2.12e-7 (unfavourable) Expressed in all Expressed in all smooth muscle: 11751.0 THNSL1 FLJ22002, TSH1 ENSG00000185875 Threonine synthase-like 1 10 25016658-25026664 Predicted intracellular proteins Evidence at protein level HPA037585 Uncertain Approved Nuclear bodies
Mitochondria
Cytosol Expressed in all Mixed thyroid gland: 14.0 TMEM223 MGC3196 ENSG00000168569 Transmembrane protein 223 11 62771629-62792021 Predicted membrane proteins Evidence at protein level HPA014504 Approved Approved Nucleus
Nuclear membrane
Mitochondria Expressed in all Expressed in all prostate: 16.9 TNNC1 TNNC ENSG00000114854 Troponin C type 1 (slow) 3 52451102-52454070 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB002450, HPA044848, HPA056897 Supported Approved Nucleoplasm
Actin filaments
Mitochondria Mixed Group enriched 15 heart muscle: 4358.3;skeletal muscle: 7106.5 esophagus: 385.2 TSPO BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS ENSG00000100300 Translocator protein (18kDa) 22 43151514-43163242 Cancer-related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level CAB011232, HPA046260 Uncertain Approved Vesicles
Mitochondria
Cytosol Liver cancer:1.61e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 301.2 UBE3C KIAA0010, KIAA10 ENSG00000009335 Ubiquitin protein ligase E3C 7 157138913-157269372 Predicted intracellular proteins Evidence at protein level HPA039915 Approved Approved Nucleoplasm
Plasma membrane
Mitochondria Renal cancer:9.18e-6 (favourable) Expressed in all Expressed in all parathyroid gland: 50.2 UGP2 UGP1, UGPP1 ENSG00000169764 UDP-glucose pyrophosphorylase 2 2 63840940-63891562 Enzymes, Predicted intracellular proteins Evidence at protein level HPA034696, HPA034697, HPA064836 Supported Approved Nucleoplasm
Centrosome
Mitochondria Liver cancer:2.50e-5 (favourable) Expressed in all Expressed in all liver: 450.1 ULK4 FAM7C1, FLJ20574, REC01035 ENSG00000168038 Unc-51 like kinase 4 3 41246599-41962430 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017930 Uncertain Approved Nucleoplasm
Mitochondria
Cytosol Mixed Tissue enhanced testis: 37.9 parathyroid gland: 14.2 UPP2 UDRPASE2, UP2, UPASE2 ENSG00000007001 Uridine phosphorylase 2 2 157876702-158136154 Enzymes, Predicted intracellular proteins Evidence at protein level HPA035225, HPA035226 Approved Nucleus
Vesicles
Mitochondria Tissue enriched Group enriched 14 kidney: 51.8;liver: 14.4 cerebral cortex: 2.4 UQCC3 C11orf83, UNQ655 ENSG00000204922 Ubiquinol-cytochrome c reductase complex assembly factor 3 11 62670273-62673687 Disease related genes, Predicted membrane proteins Evidence at protein level HPA046851 Approved Approved Nucleoplasm
Mitochondria
Cytosol Liver cancer:2.55e-4 (unfavourable) Expressed in all Expressed in all duodenum,small intestine: 8.2 USP48 FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31 ENSG00000090686 Ubiquitin specific peptidase 48 1 21678298-21783606 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA030045, HPA030046 Approved Approved Supported Nucleoplasm
Mitochondria
Cytosol Liver cancer:6.09e-8 (unfavourable) Expressed in all Expressed in all adrenal gland: 54.3 VWA5B1 FLJ32784 ENSG00000158816 Von Willebrand factor A domain containing 5B1 1 20290919-20354894 Predicted intracellular proteins Evidence at protein level HPA027496, HPA028405, HPA064829 Supported Approved Plasma membrane
Mitochondria
Cytosol Mixed Group enriched 5 epididymis: 7.9;testis: 5.0 parathyroid gland: 1.2 XAF1 BIRC4BP, HSXIAPAF1, XIAPAF1 ENSG00000132530 XIAP associated factor 1 17 6755447-6775647 Predicted intracellular proteins Evidence at protein level HPA057302 Approved Supported Nucleus
Mitochondria
Rods & Rings Renal cancer:2.73e-7 (unfavourable) Expressed in all Mixed spleen: 83.0 XK Kx, NA, NAC, X1k, XKR1 ENSG00000047597 X-linked Kx blood group X 37685759-37732130 Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA019036 Approved Approved Nucleoplasm
Vesicles
Mitochondria Mixed Mixed rectum: 12.3 ZBED2 MGC10796 ENSG00000177494 Zinc finger, BED-type containing 2 3 111592900-111595443 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA029786 Uncertain Approved Nuclear bodies
Mitochondria
Cytosol Pancreatic cancer:8.83e-4 (unfavourable) Tissue enriched Tissue enhanced fallopian tube: 30.1;thyroid gland: 112.7 lung: 15.0 ZDHHC20 FLJ25952 ENSG00000180776 Zinc finger, DHHC-type containing 20 13 21372573-21459370 Enzymes, Predicted membrane proteins Evidence at protein level HPA014483, HPA014702 Approved Uncertain Vesicles
Plasma membrane
Mitochondria Renal cancer:1.01e-4 (unfavourable), Pancreatic cancer:6.55e-4 (unfavourable) Expressed in all Expressed in all testis: 60.4 ZKSCAN1 KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33 ENSG00000106261 Zinc finger with KRAB and SCAN domains 1 7 100015572-100041689 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006672 Uncertain Approved Nucleus
Nuclear bodies
Mitochondria Expressed in all Expressed in all skin: 39.1 ZNF445 ZKSCAN15, ZNF168, ZSCAN47 ENSG00000185219 Zinc finger protein 445 3 44431720-44477670 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006678 Uncertain Approved Nucleus
Mitochondria
Cytosol Expressed in all Mixed parathyroid gland: 7.1 ZNF678 MGC42493 ENSG00000181450 Zinc finger protein 678 1 227563543-227677443 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA028507 Uncertain Approved Nucleoli
Mitochondria
Cytosol Expressed in all Mixed thyroid gland: 9.0 ZNF787 ENSG00000142409 Zinc finger protein 787 19 56087366-56121280 Predicted intracellular proteins Evidence at protein level HPA035140 Supported Approved Nucleus
Nucleoli
Mitochondria Expressed in all Expressed in all spleen: 19.7